QNME · Quanome Technologies, Inc.
$0.50
-0.04 (-7.23%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 25, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As discussed in Note 2 to the consolidated financial statements, the Company's recurring net losses, negative cash flows from operations and accumulated deficit raised substantial doubt about its ability to continue as a going concern. These factors, among others, raise the substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-K filed Sep 25, 2026
Market Cap
$18.44M
Shares
34.43M
Volume · Oct 20
512.94K
Avg daily vol (3M)
14.88M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.47
Open$0.54
Day$0.46–0.54
Available close range$0.26–0.85
Avg vol 30d22.3M
Short int464K · 1.3% float · 1.0d
Short vol42%
Last earningsMay 15, 2025
DataJul 2026–Oct 2026
Filing10-K · Sep 25
The closing range uses available history since Jul 27, 2026; less than a full year is stored.
Up next
filed Sep 25, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$5.85M
Trailing 12 months
Net income (TTM)
−$9.48M
Trailing 12 months
Revenue growth YoY
+111.8%
Year over year
Operating margin
-174.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$800,775
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+359.0%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.3%
Latest settlement · 1.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Limited
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−2%
below
RSI (14)
45
neutral
MACD trend
Negative
52-week position
37%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
0% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.35% of float · ▼ -54.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 2-yr range
Squeeze score
34
low risk · 0–100
Fundamentals
Revenue growth
+112%
Y/Y
Gross margin
57%
expanding
EPS growth
+48%
Y/Y
Free cash flow
$-2.7M
Balance sheet
$3.5M
net cash
Quant / Vol
risk profile
Volatility
359%
annualized · 1-yr
Max drawdown
−59%
past year
ATR
25.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−2%
Neutral
RSI (14)
45
Neutral
MACD trend
Negative
Bearish
52-week position
37%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
0% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.35% of float · ▼ -54.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 2-yr range
Price context
position in its available closing range
Range low $0
Now $0 · 37%
Range high $1
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Active customers | 12 | year ended June 30, 2026 filing | — |
| Infusion products as a percentage of pharmaceutical distribution revenue | 91.1% | year ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Integrated Freight & Logistics — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
QNME
this stock
Quanome Technologies, Inc.
|
$18.44M | — | +111.8% | — | 1.3% |
|
UPS
United Parcel Service Inc
|
$83.91B | -0.7% | +8.2% | — | 3.3% |
|
FDX
Fedex Corp
|
$69.50B | — | +8.5% | 15.7 | 2.3% |
|
EXPD
Expeditors International Of Washington Inc
|
$25.58B | +33.2% | +13.5% | 28.6 | 3.4% |
|
JBHT
Hunt J B Transport Services Inc
|
$20.97B | +16.5% | +9.7% | 31.7 | 3.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| QNME | -26.6% | -44.3% | — | -10.9% | — |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | -25.4% | -43.7% | — | -11.7% | — |